GB1480092A - Diagnostic agent - Google Patents

Diagnostic agent

Info

Publication number
GB1480092A
GB1480092A GB35755/74A GB3575574A GB1480092A GB 1480092 A GB1480092 A GB 1480092A GB 35755/74 A GB35755/74 A GB 35755/74A GB 3575574 A GB3575574 A GB 3575574A GB 1480092 A GB1480092 A GB 1480092A
Authority
GB
United Kingdom
Prior art keywords
surface area
composition
per cent
blood platelet
diagnostic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35755/74A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Priority to GB35755/74A priority Critical patent/GB1480092A/en
Publication of GB1480092A publication Critical patent/GB1480092A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1480092 Diagnostic agent for coagulation factors WARNER-LAMBERT CO 14 Aug 1974 35755/74 Heading G1B A lyophilized diagnostic reagent comprises a blood platelet substitute containing cephalin having platelet factor-like activity (defined) combined with 0À05-1À0 wt per cent, based on the composition, of non-porous fumed silica of 20-60 mÁ particle size and 50 m<SP>2</SP>/g surface area. The silica preferably has <3 silcenol groups/100Š<SP>2</SP> surface area. The reagent may also contain calcium free acacia, tragacanth, guargum, dextran or sucrose. Prior to lyophilization the composition may contain 0À5-3À0 wt per cent suspending agent and have a pH of about 7À35. The blood platelet substitute may be a mammalian brain extract.
GB35755/74A 1974-08-14 1974-08-14 Diagnostic agent Expired GB1480092A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB35755/74A GB1480092A (en) 1974-08-14 1974-08-14 Diagnostic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB35755/74A GB1480092A (en) 1974-08-14 1974-08-14 Diagnostic agent

Publications (1)

Publication Number Publication Date
GB1480092A true GB1480092A (en) 1977-07-20

Family

ID=10381226

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35755/74A Expired GB1480092A (en) 1974-08-14 1974-08-14 Diagnostic agent

Country Status (1)

Country Link
GB (1) GB1480092A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2132759A (en) * 1979-09-11 1984-07-11 Terumo Corp Blood collecting tube
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2132759A (en) * 1979-09-11 1984-07-11 Terumo Corp Blood collecting tube
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11609043B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11740019B2 (en) 2019-03-14 2023-08-29 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11747082B2 (en) 2019-03-14 2023-09-05 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11815311B2 (en) 2019-03-14 2023-11-14 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11994343B2 (en) 2019-03-14 2024-05-28 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use

Similar Documents

Publication Publication Date Title
EP0259475A4 (en) Recombinant human endothelial cell growth factor.
Bernacki et al. Red cell hydrolases: II. Proteinase activities in human erythrocyte plasma membranes
DE69120550D1 (en) Process for the production of thrombin and the highly purified thrombin composition obtained therefrom
GB1487717A (en) Diagnostic agent for the detection of protein in body fluids
ES469328A1 (en) Glycoprotein and process for isolating it
ES8505405A1 (en) Novel purified plasminogen activator, process for its production and thrombolytic composition containing it.
AU4065189A (en) Contrast preparation consisting of cavitate- or clathrate- forming host/guest complexes
ES8603271A1 (en) Stable composition of interleukin-2.
CA2071196A1 (en) Recombinant expression vectors and purification methods for thermus thermophilus dna polymerase
DE69003253D1 (en) ENZYMED PREPARATION AND DETERGENT CONTAINING SUCH A PREPARATION.
ATE92523T1 (en) METHODS FOR SEPARATION AND PURIFICATION OF SIALYL TRANSFER LASES.
Dixit et al. Isolation of the fibrinogen-binding region of platelet thrombospondin
GB1525449A (en) Cosmetic preparation containing agents for keeping the skin moist
KR890003952A (en) New Tissue Plasminogen Activator
Burrowes et al. The kinin system of human plasma VI. The action of plasmin
DE68921371D1 (en) Process for the preparation of a fraction enriched in factor VIIa and its use as a medicament.
ES2041249T3 (en) LIQUID PREPARATIONS OF 1,2-BENZOISOTIAZOLIN-3-ONA, ITS OBTAINING AND USE.
GB1263589A (en) Solid catalysts containing silicon phosphate, their manufacture and use
GB1480092A (en) Diagnostic agent
ES2012128A6 (en) Method for regulating plant growth using sulfur-containing organic acids.
ES8707565A1 (en) Monoclonal antibodies to tissue plasminogen activator derived from human normal cells.
ATE60780T1 (en) PROCESS FOR THE PREPARATION OF ALKYLOLIGOGLYCOSIDES.
DE3879575T2 (en) Alpha carotene to inhibit the growth of cancer cells.
ES2002015A6 (en) [[[(3-Pyridinyl)methylen]amino]oxy]alkanoic acids and esters.
GB1519285A (en) Composition

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee